Gene · 369
NIH grants1,471
NIH grants whose papers are about the gene, through NIH's grant-paper links.
781 to 800 of 1,471
Download this page as JSON| Grant | Title | ARAF papers | Newest fiscal year |
|---|---|---|---|
| P50GM085764 | San Diego Center for Systems Biology: From Maps to Models | 1 | 2018 |
| R00CA181342 | Elucidating a Novel Akt Activation Mechanism for Targeted Prostate Cancer Therapy | 1 | 2018 |
| R01AG046544 | Modeling Splicing in normal tissues and neurodegenerative disease | 1 | 2018 |
| R01CA123031 | Dynamic requirements of Ras signaling during cancer | 1 | 2018 |
| R01CA132630 | Chemical Probes for Metabolic Pathway Discovery in Human Disease | 1 | 2018 |
| R01CA176203 | MicroRNA128 Regulation of Polycomb Repressor Complexes1 and 2 in Glioblastoma | 1 | 2018 |
| R01CA176401 | RB Function in Prostate Cancer Progression | 1 | 2018 |
| R01CA181429 | Radiation and Receptor Targeted RadioTheranostic Nanoparticles for Glioblastoma | 1 | 2018 |
| R01CA187238 | Therapeutic Strategies for Patients With BRAF Mutant Colorectal Cancer | 1 | 2018 |
| R01CA187342 | Role of extracellular Hsp90 in epithelial cell polarity and invasion | 1 | 2018 |
| R01CA188048 | Investigating a novel glutamine metabolism pathway in pancreatic cancer | 1 | 2018 |
| R01CA201204 | Targeting protein-protein interactions of Bmi1 oncoprotein | 1 | 2018 |
| R01DK066483 | PGC-1 & Muscle Mitochondrial Dysfunction in Diabetes | 1 | 2018 |
| R01DK081579 | Role of Periostin in Polycystic Kidney Disease | 1 | 2018 |
| R01DK103658 | Optimization of novel inhibitors of TRPC5 as anti-proteinuric therapeutics | 1 | 2018 |
| R01DK107288 | S-Adenosylmethionine in Protein Posttranslational Modifications and HCC Treatment | 1 | 2018 |
| R01GM036652 | Microfilament Organization and Regulation | 1 | 2018 |
| R01GM089763 | Interplay between Cdh1 and major regulatory pathways in human cancer | 1 | 2018 |
| R01GM095567 | Mechanisms of Selective Autophagy | 1 | 2018 |
| R01GM100387 | Transfer Rule Learning with Functional Mapping for Integrative Modeling of Panomics Data | 1 | 2018 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/grants?page=40